heart failure Archives - Page 2 of 3

Emerging concepts in heart failure management and treatment: focus on vericiguat

Edgardo Kaplinsky, Sergio Perrone, Alejandro Barbagelata

Article Type

Review

Published

04 Jan 2023

This review provides comprehensive information about vericiguat in terms of its differential mechanism of action and clinical data particularly focused on the VICTORIA trial.

Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy

María Victoria Báez Cabanillas, Roberto Colque, Miguel Ángel Tibaldi, Edgardo Kaplinsky, Sergio Perrone, Alejandro Barbagelata

Article Type

Review

Published

04 Jan 2023

The author present a narrative review that comprehensively addresses the pathophysiology, clinical manifestations, and therapeutic management of tachycardia-induced cardiomyopathy.

Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO)

Federico Swedzky, Alejandro Barbagelata, Sergio Perrone, Edgardo Kaplinsky, Anique Ducharme

Article Type

Review

Published

04 Jan 2023

The authors present a literature review which provides simple information, evidence-based indications, and a practical approach for cardiologists who may encounter acutely ill adult patients that may be extracorporeal membrane oxygenation candidates.

The impact of antidepressants on depressive symptom severity, quality of life, morbidity, and mortality in heart failure: a systematic review

Rebecca Hedrick MD, Samuel Korouri BA, Emile Tadros BS, Tarneem Darwish MD, Veronica Cortez RN, OD, Desiree Triay RN, Mia Pasini RN, MSN, Linda Olanisa LCSW, Nathalie Herrera MD, Sophia Hanna BA, MA, Asher Kimchi MD, Michele Hamilton MD, Itai Danovitch MD, MBA, Waguih William IsHak MD, FAPA

Article Type

Original Research

Published

29 Jul 2020

This article reviews the literature on the impact of antidepressants on depressive symptom severity, quality of life, morbidity, and mortality in patients with heart failure.

The metabolic model of heart failure: the role of sodium glucose co-transporter-2 (SGLT-2) inhibition

Muhammad Saad MD, Umut Gomceli MD, Pranav Ravi MD, Andrisael G Lacoste MD, Neil Shah MD, Timothy J Vittorio MD

Article Type

Review

Published

21 Nov 2018

In the recent era, SGLT-2 inhibitors have shown success in decreasing cardiovascular mortality in the type 2 diabetes mellitus population. This article will help the reviewer to comprehend the pathophysiology of heart failure and the potential role of SGLT-2 inhibitors in the management algorithm of heart failure and its associated risk factors in type 2 diabetes mellitus.